Day 2

Oxytocin begets large-scale cooperation: A biobehavioral mechanism for the dynamic spread of cooperation in human social networksYina Ma, China Brain networks under acute stressRongjun Yu, Hong Kong Examining flexible decision-making in compulsive disorders and after pharmacological challenges using computational modellingJonathan Kanen, UK Precision pharmaco-imaging: development and application of a neuroimaging-based fear signatureBenjamin Becker, China Chairperson:  …

Andrea Fagiolini, Italy Philip Gorwood, France Chairpersons:  Chay Hoon Tan, Singapore This session is made possible by kind support from Lundbeck.

Professor Tadafumi Kato Head of Department of Psychiatry and Behavioral Science, Juntendo University Graduate School of Medicine. Tokyo, Japan Professor Zhong Chen President of Zhejiang Chinese Medical University, and also the Prof of School of Medicine, Zhejiang University,  Hangzhou, Zhejiang Province, China   Chairperson: Chay Hoon Tan

Prescription of unfavorable combinations of drugs for mood disorders and physical conditions: a cross-sectional national database surveyTaisuke Yatomi, Japan Real-world effectiveness of antipsychotic treatments in a psychiatric emergency cohort of 1011 patients with schizophreniaKotaro Hatta, Japan High Dose Mood Stabiliser use and Clinical Correlates Amongst Patients with Bipolar Disorder in Asia: Research on Asian Psychotropic …

Genetic association between COVID-19 and substance use disordersShinya Kasai, Japan Using Psychotropic Drugs to Treat Long-Covid SyndromeRoger McIntyre, Canada A chain mediation model on COVID-19 symptoms and mental health outcomes in America, Asia and EuropeRoger Ho, Singapore Feasibility and Effectiveness of Art therapies for improving health and well-being of children during COVID-19: A global synthesisMinh-Anh …

Pharmacological Strategies in Complex ADHDTimothy E Wilens, USA Advanced psychopharmacologic treatment for Child and Adolescent with Autism Spectrum DisorderJoshi Gagan, USA Chairperson: John Wong, Singapore This session is made possible by kind support from Hyphens.

Future of Psychiatry: Role of TechnologyXin-Min Li, Canada Advances in psychotherapy/pharmacotherapy enhanced neuromodulation in treating major depressive disorderYanbo Zhang, Canada TBCYuan-Hwa Chou, Taiwan Pipeline Medications for SchizophreniaLin Shih Ku Chairperson: Lin Shih Ku, Taiwan

Efficacy and safety of adjunctive aripiprazole, metformin and paeoniae-glycyrrhiza decoction for antipsychotic-induced hyperprolactinemia: a network meta-analysis of randomized controlled trialsHan Qi, China Meta-analysis of randomized, double-blind, placebo-controlled trials of melatonin in Alzheimer’s diseaseYuan Yuan Wang, UK Efficacy and safety of traditional Chinese herbal medicine for antipsychotic-related constipation: a systematic review and meta-analysis of randomized controlled …

Depression is a complex and often chronic illness. Improving health outcomes in depression begins with improving characterization of the illness in those affected. Ecological momentary assessment (EMA) provides opportunity for passive and ambient collection of data that EMA devices suggest can determine whether a patient is depressed or not. Notwithstanding the availability of multiple app-based …

In 2009 we published one of the earlier network meta-analyses (NMA) of 12 new generation antidepressants in the acute phase treatment of depression 1. In 2018 we expanded and updated this NMA by including five more new generation antidepressants and four old antidepressants (522 trials, 116 477 participants) 2. The major difficulty in these endeavors …